Danske Bank’s West Pharmaceutical WST Stock Holding History

Danske Bank’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.6M	Buy	32,429 +1,181	+4%	+$361K	0.02%	431
2026 Q1	$7.83M	Sell	31,248 -2,269	-7%	-$565K	0.02%	476
2025 Q4	$9.22M	Buy	33,517 +1,654	+5%	+$452K	0.02%	454
2025 Q3	$8.36M	Buy	31,863 +1,754	+6%	+$426K	0.02%	461
2025 Q2	$6.59M	Buy	30,109 +2,076	+7%	+$444K	0.02%	497
2025 Q1	$6.28M	Sell	28,033 -7,718	-22%	-$2.13M	0.02%	496
2024 Q4	$11.7M	Buy	35,751 +4,227	+13%	+$1.33M	0.04%	384
2024 Q3	$9.46M	Buy	31,524 +2,781	+10%	+$852K	0.03%	400
2024 Q2	$9.47M	Sell	28,743 -1,951	-6%	-$689K	0.03%	381
2024 Q1	$12.1M	Buy	+30,694	New	+$11.4M	0.04%	382

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Danske Bank's WST Position: Q2 2026 in Review

Danske Bank increased its West Pharmaceutical (WST) stake by 3.8% in Q2 2026, buying an estimated $361K and bringing the position to 32,429 shares worth $11.6M. The position accounts for 0.02% of the portfolio, ranked #431.

Danske Bank first reported a position in WST in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.1M in Q1 2024. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Danske Bank held 32,429 shares of West Pharmaceutical worth $11.6M as of Q2 2026.
Danske Bank bought 1,181 West Pharmaceutical shares in Q2 2026, an estimated $361K.
West Pharmaceutical made up 0.02% of Danske Bank's portfolio in Q2 2026, its #431 holding.
Danske Bank first reported a position in West Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
Danske Bank's West Pharmaceutical position peaked at $12.1M in Q1 2024.
833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.